Search the Newsreel

Why Civista Bancshares (CIVB) is a Top Dividend Stock for Your Portfolio

Civeo stock trades around recent highs as earnings and cash flow support valuation

Civeo stock is trading near recent highs, supported by solid earnings growth, improved margins, and strong free cash flow. The company, an accommodation specialist for remote workforces, has focused on disciplined capital allocation and debt reduction, contributing to its stable equity story despite cyclical …

Trump has made 29 private prison stock trades since taking office

Former President Trump's brokers executed 29 trades of private prison stocks since he re-entered office, totaling between $281,029 and $990,000, primarily in GEO Group and CoreCivic. These companies saw massive growth and profits in 2025, attributing it to Trump's immigration policies, even as conditions …

CoreCivic stock hits 52-week high at 32.6 USD

CoreCivic Inc (CXW) stock reached a new 52-week high of $32.6, trading just 1% below this peak and showing significant gains over the last year and year-to-date. Despite its strong performance, an InvestingPro analysis suggests the stock might be overvalued relative to its Fair …

CoreCivic Inc (CXW) Shares Surge 3.9% -- What GF Score of 63 Tel

CoreCivic Inc (CXW) shares recently surged 3.9%, but GuruFocus's GF Value™ indicates the stock is significantly overvalued by 44.4%. Despite an above-average GF Score™ of 63/100, driven by strong profitability, the company exhibits poor growth and momentum, along with significant insider selling which suggests …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating Unicycive Therapeutics, Inc. (UNCY) after the FDA issued a second Complete Response Letter for its kidney disease therapy, oxylanthanum, citing unresolved manufacturing deficiencies. The law firm is encouraging investors who purchased Unicycive securities to join their investigation …

CoreCivic, Inc. $CXW Stock Holdings Lowered by Hahn Capital Management LLC

Hahn Capital Management LLC reduced its stake in CoreCivic, Inc. (NYSE:CXW) by 15.5% in the first quarter, selling 37,476 shares and leaving it with 203,846 shares valued at $3.86 million. Despite this reduction from one firm, other institutional investors increased their positions, with 85.13% …

(CIVB) and the Role of Price-Sensitive Allocations

This article provides a detailed stock analysis for Civista Bancshares Inc. (NASDAQ: CIVB), highlighting strong near-term sentiment with a long-term positive bias. It presents three institutional trading strategies tailored for different risk profiles—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, including …

Citizens Bank to cut ties with CoreCivic and GEO after a fierce public pressure campaign

Citizens Bank announced it will wind down its financial relationships with private prison companies CoreCivic and The GEO Group. This decision follows a public pressure campaign from advocates and city governments, who criticized the bank for its ties to companies running immigration detention centers …

CoreCivic, Inc. (NYSE:CXW) Short Interest Update

CoreCivic, Inc. (NYSE:CXW) experienced a significant 35.4% decrease in short interest during June, falling to 1,812,744 shares as of June 30th. This represents a short-interest ratio of 1.0 days and about 1.9% of shares shorted. Despite a slight dip in stock price, analyst sentiment …

Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential securities claims against Unicycive Therapeutics, Inc. following a stock drop. This investigation stems from the FDA issuing a second Complete Response Letter for Unicycive's kidney disease therapy, citing manufacturing deficiencies. The law firm is encouraging investors …

Civista Bancshares, Inc. (NASDAQ:CIVB) Short Interest Up 81.2% in June

Civista Bancshares (NASDAQ:CIVB) experienced an 81.2% surge in short interest in June, reaching 495,011 shares, equivalent to 2.4% of its float. Despite softening analyst sentiment with some downgrades to "Hold," Piper Sandler raised its price target to $30, and the company reported better-than-expected quarterly …

Civista Bancshares (CIVB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Civista Bancshares (CIVB) is expected to report a year-over-year increase in earnings and higher revenues for the quarter ended June 2026. While the company's Zacks Rank is #3 (Hold), its Earnings ESP of -0.75% suggests analysts have become more bearish recently, making a conclusive …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Unicycive Therapeutics, Inc. (UNCY) following a significant drop in its stock price. This investigation comes after the FDA issued a second Complete Response Letter for Unicycive's kidney disease therapy, oxylanthanum, citing unresolved third-party manufacturing …

Civista Bancshares (CIVB) to Release Quarterly Earnings on Thursday

Civista Bancshares (NASDAQ:CIVB) is scheduled to release its Q2 2026 earnings before market open on Thursday, July 23rd. Analysts anticipate earnings of $0.67 per share on revenue of $48.08 million. The bank surpassed expectations in its previous quarter, reporting $0.74 EPS against an estimated …

Latham Advises on Civeo’s US$100 Million Offering of Convertible Senior Notes

Latham & Watkins LLP advised the initial purchasers on Civeo Corporation's recent US$100 million offering of 4.50% convertible senior notes due 2031. The private offering involved a corporate deal team from Latham, alongside specialists in tax, environmental, and benefits matters. Ryan Maierson, Greg Rodgers, …

Protesters Gather Outside California City Hall to Speak Out Against CoreCivic

Community members protested outside California City Hall on July 7 against CoreCivic, raising concerns about the treatment of immigrants in detention facilities. Speakers shared personal stories of alleged mistreatment, poor living conditions, and lack of medical care, calling for immigration reform and greater transparency. …

Unicycive Therapeutics (UNCY) Gets a Buy from Maxim Group

Maxim Group analyst Jason McCarthy reiterated a Buy rating for Unicycive Therapeutics (UNCY) with a $30.00 price target, despite the company's recent quarterly GAAP net loss of $12.82 million. The Street maintains a Strong Buy consensus with an average price target of $36.71. Benchmark …

CoreCivic sets Aug. 5 Q2 results call, webcast Aug. 6

Vipul Khurana buys 18,335 shares in Globe Civil Projects

Earnings Troubles May Signal Larger Issues for Globe Civil Projects (NSE:GLOBECIVIL) Shareholders

CoreCivic’s Weaker Cash Flows Raise Questions On Earnings Quality

Globe Civil Projects reports FY26 revenue of ₹4,090.39 million

Civista Bancshares (CIVB) Could Be a Great Choice

CoreCivic (CXW): Buy, Sell, or Hold Post Q1 Earnings?

The 5 Most Interesting Analyst Questions From CoreCivic’s Q1 Earnings Call

Assessing CoreCivic (CXW) Valuation As Shares Trade Below Earnings And DCF Estimates

CoreCivic Q1 Earnings Call Highlights

CoreCivic (NYSE:CXW) Posts Better-Than-Expected Sales In Q1 CY2026

CoreCivic buys mail-order pharmacy company, raises 2026 outlook

Do Insider Sales and Earnings Hopes Reveal a Deeper Shift in CoreCivic’s (CXW) Profit Strategy?

CoreCivic Earnings: What To Look For From CXW

Civista Bancshares, Inc. Announces First-Quarter 2026 Financial Results of $0.72 per Common Share, up $0.06 per Common Share from First-Quarter 2025

Globe Civil Projects Reports ₹730 Crore Order Book with Major Project Wins

Globe Civil Projects Limited Receives Rating Upgrade Before Infomerics Withdraws Credit Ratings

CoreCivic (NYSE:CXW) Q4 Earnings: Leading The Safety & Security Services Pack